Cargando…
Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis
BACKGROUND & AIMS: Current guidelines recommend immunosuppressive treatment (IT) in patients with primary sclerosing cholangitis (PSC) and elevated aminotransferase levels more than five times the upper limit of normal and elevated serum IgG-levels above twice the upper limit of normal. Since th...
Autores principales: | Schulze, Kornelius, Weismüller, Tobias J., Bubenheim, Michael, Huebener, Peter, Zenouzi, Roman, Lenzen, Henrike, Rupp, Christian, Gotthardt, Daniel, de Leuw, Philipp, Teufel, Andreas, Zimmer, Vincent, Reiter, Florian P., Rust, Christian, Tharun, Lars, Quaas, Alexander, Weidemann, Sören A., Lammert, Frank, Sarrazin, Christoph, Manns, Michael P., Lohse, Ansgar W., Schramm, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619354/ https://www.ncbi.nlm.nih.gov/pubmed/26489083 http://dx.doi.org/10.1371/journal.pone.0140525 |
Ejemplares similares
-
Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis
por: Keller, Sarah, et al.
Publicado: (2018) -
Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis
por: Ehlken, Hanno, et al.
Publicado: (2016) -
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
por: Rühlemann, Malte, et al.
Publicado: (2019) -
Impact on follow‐up strategies in patients with primary sclerosing cholangitis
por: Bergquist, Annika, et al.
Publicado: (2022) -
Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis
por: Gauss, Annika, et al.
Publicado: (2016)